does tirzepatide cause thyroid cancer Retatrutide and Cancer: Why the Warning Exists ⚠️Cancer Concerns Around Popular Weight-Loss

Click on the Pharmacy tab

More expensive yearly cost

Additional TRIUMPH and Other Phase 3 Trials Lilly has initiated or announced additional Phase 3 trials for retatrutide: Chronic low back pain -- Phase 3 initiated in Q3 2025 Overweight/obesity (additional) -- new Phase 3 trial initiated in Q3 2025 MASLD master protocol (NCT07165028) -- a Phase 3 multi-agent master protocol in MASLD that includes retatrutide (not a dedicated retatrutide-only liver trial), building on the Phase 2 liver fat sub-study TRANSCEND Program -- Type 2 Diabetes TRANSCEND Phase 3 program evaluating retatrutide specifically for type 2 diabetes

As observed previously 13 , the putative flavan-3,3,4-triol ( 4 ) was not stable during purification, and confirmatory time-course experiments showed almost complete degradation of the intermediate ( 4 ) within 24 h (Extended Data Fig